Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia

Blood

Volumn 89, Issue 5, 1997, Pages 1701-1707

  Chen, Chun Lin ^b   Liu, Qing ^b   Pui, Ching Hon ^b   Rivera, Gaston K ^b   Sandlund, John T ^b   Ribeiro, Raul ^b   Evans, William E ^b   Relling, Mary V ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD CELL COUNT; CELL DIFFERENTIATION; DNA SYNTHESIS INHIBITION; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOBLAST; PRIORITY JOURNAL; STRUCTURAL GENE; TREATMENT OUTCOME;

EID: 0031032786     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1701     Document Type: Article

References (46)

1. Ross JA, Potter JD, Robison LL: Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 86:1678, 1994
2. Ross JA, Davies SM, Potter JD, Robison LL: Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev 16:243, 1994
3. Greaves MF, Colman SM, Beard MEJ, Bradstock K, Cabrera ME, Chen P, Jacobs P, Lam-Po-Tang PRL, MacDougall LG, Williams CKO, Alexander FE: Geographical distribution of acute lymphoblastic leukaemia subtypes: Second report of the collaborative group study. Leukemia 7:27, 1993
4. Buckley JD, Buckley CM, Ruccione K, Sather HN, Waskerwitz MJ, Woods WG, Robison LL: Epidemiological characteristics of childhood acute lyrnphocytic leukemia analysis by immunophenotype. Leukemia 8:856, 1994
5. Kaye SA, Robison LL, Smithson WA, Gunderson P, King FL, Neglia JP: Matemal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer 68:1351, 1991
6. Alexander FE, Ricketts TJ, McKinney PA, Cartwright RA: Community lifestyle characteristics and risk of acute lymphoblastic leukaemia in children. Lancet 336:1461, 1990
7. Blumer JL, Dunn R, Esterhay MD, Yamashita TS, Gross S: Lymphocyte aromatic hydrocarbon responsiveness in acute leukemia of childhood. Blood 58:1081, 1981
8. Andersson C, Mosialou E, Weinander R, Morganstern R: Enzymology of microsomal glutathione S-transferase. Adv Pharmacol 27:19, 1994
9. Ketterer B, Christodoulides LG: Enzymology of cytosolic glutathione S-transferase. Adv Pharmacol 27:37, 1994
10. Guengerich FP, Thier R, Persmark M, Taylor JB, Pemble SE, Ketterer B: Conjugation of carcinogens by Theta class glutathione S-transferase: Mechanisms and relevance to variations in human risk. Pharmacogenetics 5:S103, 1995
11. Guengerich FP: Metabolism and genotoxicity of dihaloalkanes. Adv Pharmacol 27:211, 1994
12. Tsuchida S, Sato K: Glutathione transferases and cancer. CRC Crit Rev Biochem Mol 27:337, 1992
13. Tew KD: Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313, 1996
14. Seidegard J, Pero RW, Miller DG, Beattie EJ: A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7:751, 1986
15. Bell D, Thompson C, Taylor J, Miller C, Perera F, Hsieh L, Lucier G: Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: Application of glutathione transferase mu. Environ Health Perspect 98:113, 1992
16. Lin T, Matsuzaki G, Yoshida H, Kobayashi N, Kenai H, Omoto K, Nomoto K: CD3-CD8+ intestinal intraepithelial lymphocytes (JEL) and the extrathymic development of IEL. Eur J Imrnunol 24:1080, 1994
17. Chen G, Liu Q, Relling MV: Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6:187, 1996
18. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB: Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271, 1994
19. Warwick A, Sarhanis P, Redman C, Pemble S, Taylor JB, Ketterer B, Jones P, Alldersea J, Gilford J, Yengi L, Fryer A, Strange RC: Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: Interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 15:2841, 1994
20. Nelson HH, Wiencke JK, Christian DC, Cheng TJ, Zuo Z, Schwartz BS, Lee B, Spitz MR, Wang M, Xu X, Kelsey KT: Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 16:1243, 1995
21. Hirvonen A, Nylund L, Kociba P, Husgafvel-Pursiainen K, Vainio H: Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers [published erratum appears in Carcinogenesis 15:1767, 1994]. Carcinogenesis 15:813, 1994
22. Nakachi K, Imai K, Hayashi S, Kawajiri K: Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53:2994, 1993
23. Lafluente A, Pujol F, Carretero P, Villa JP, Cuchi A: Human glutathione S-transferase mu (GSTmu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 68:49, 1993
24. Nazar-Steward V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng ZT, Stapleton P, Weiss NS: The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53:2313, 1993
25. Harada S, Misawa S, Nakamura T, Tanaka N, Ueno E, Nozoe M: Detection of GST1 gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese. Hum Genet 90:62, 1990
26. Fryer AA, Zhao L, Aldersea J, Bogglid MD, Perrett CW, Clayton RN, Jones PW: The glutathione S-transferase: Polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis 14:563, 1993
27. Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S: Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 15:1077, 1994
28. Strange RC, Fryer AA, Matharoo B, Zhao L, Broome J, Campbell DA, Jones P, Pastor IJ, Singh RVP: The human glutathione S-transferases: Comparison of isoenzyme expression in normal and astrocytoma brain. Biochem Biophys 1139:222, 1992
29. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA: Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295, 1996
30. Hall AG, Autzen P, Cattan AR, Malcolm AJ, Cole M, Kernahan J, Reid MM: Expression of mu class glutathione s-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia. Cancer Res 54:5251, 1994
31. Bell D, Taylor J, Paulson D, Robertson C, Mohler J, Lucier G: Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increase susceptibility to bladder cancer. J Natl Cancer Inst 85:1159, 1996
32. Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui C, Abromowitch M, Mirro J, Ochs J, Look AT, Murphy SB, Dahl GV, Kalwinsky DK, Evans WE, Kun L, Simone JV, Grist WM: Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337:61, 1991
33. Pui C-H, Simone JV, Hancock ML, Evans WE, Williams DL, Bowman WP, Dahl GV, Dodge RK, Ochs J, Abromowitch M, Rivera GK: Impact of three methods of treatment intensification on acute tymphoblastie leukemia in children: Long-term results of St. Jude Total Therapy Study X. Leukemia 6:150, 1992
34. Evans WE, Rodman J, Relling MV, Crom WR, Rivera GK, Crist WM, Pui C: Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia. Semin Hematol 28:15, 1991
35. Pui CH, Relling MV, Behm FG, Hancock ML, Boyett JM, Raimondi SC, Krance RA, Mahmoud HH, Ribeiro RC, Sandlund JT, Head DR, Evans WE, Crist WM, Rivera GK: L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia 9:1680, 1995
36. McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE: Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 55:15, 1994
37. Groves FD, Linet MS, Devesa SS: Patterns of occurrence of the leukaemias. Eur J Cancer 31A:941, 1995
38. Greaves MF, Pegram SM, Chan LC: Collaborative group study of the epidemiology of acute lymphoblastic leukaemia subtypes: Background and first report. Leuk Res 9:715, 1985
39. Pui C-H: Acute leukemia in children. Curr Opin Hematol 3:249, 1996
40. Kalwinsky DK, Rivera G, Dahl GV, Roberson P, George S, Murphy SB, Simone JV: Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: Implications for treatment outcome. Leuk Res 9:817, 1985
41. Pui C, Boyett JM, Hancock ML, Pratt CB, Meyer WH, Crist WM: Outcome of treatment for childhood cancer in black as compared with white children. JAMA 273:633, 1995
42. Falletta JM, Boyett J, Pullen DJ, Crist W, Dowell B, Roper M, Humphrey GB, Metzgar R, Cooper MD, van Eys J: Clinical and phenotypic features of childhood acute lymphocytic leukemia in whites, blacks, and hispanics: A pediatric oncology group study, in Magrath IT, O'Conor GT, Ramot B (eds): Environmental Influences. New York, NY, Raven, 1984
43. Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ: A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55:3757, 1995
44. Miller RW, Young JL, Novakovic B: Childhood cancer. Cancer 75:395, 1995
45. Pui CH, Williams DL, Raimondi SC, Rivera GK, Look AT, Dodge RK, George SL, Behm FG, Crist WM, Murphy SB: Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood 70:247, 1987
46. Raimondi SC, Roberson PK, Pui CH, Behm FG, Rivera GK: Hyperdiploid (47-50) acute lymphoblastic leukemia in children. Blood 79:3245, 1992